Viewing StudyNCT06488911



Ignite Creation Date: 2024-07-17 @ 11:10 AM
Last Modification Date: 2024-10-26 @ 3:34 PM
Study NCT ID: NCT06488911
Status: ENROLLING_BY_INVITATION
Last Update Posted: 2024-07-05
First Post: 2024-06-28

Brief Title: To Evaluate Safety and Tolerability of the Fixed- Dose Combination of Obeticholic Acid and Bezafibrate
Sponsor: Intercept Pharmaceuticals
Organization: Intercept Pharmaceuticals

Conditions & Keywords Data

Conditions:
Name
Primary Biliary Cholangitis
Keywords:
Name View
Primary Biliary Cholangitis View
Obeticholic Acid View
Bezafibrate View
Ursodeoxycholic acid View